Skip to content
Screener

Cencora COR Return on equity

Return on equity at other companies

Eli Lilly logo
Eli LillyLLY
107.6%+29.9pp
United Parcel Service, Inc. logo
United Parcel Service, Inc.UPS
29.6%-5.3pp
CryoPort, Inc. logo
CryoPort, Inc.CYRX
14.5%+8.6pp
AbbVie logo
AbbVieABBV
89%+32.7pp
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-52.8%-12.7pp
Viatris logo
ViatrisVTRS
-2%-0.9pp

Other financials

Income statement

See full
Revenue$78.4B+3.8%
Gross profit$3.6B+17.3%
Operating income$1.1B+10.3%
Net income$1.6B+129%
EPS (diluted)$8.40+128%

Balance sheet

See full
Cash & equivalents$2.2B+10.0%
Total debt$12.2B+71.9%
Total equity$3.4B+235%
Total assets$81.7B+14.7%

Cash flow

See full
Operating cash flow-$2.3B+15.2%
CapEx$165.6M+28.3%
Free cash flow-$2.4B+14.2%

Valuation

See full
Market cap$60.57B+6.4%
Enterprise value$70.58B+12.5%
P/E16.8×+3.4×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.4pp
Operating margin0.8%0.0pp
Net margin0.6%-0.1pp
FCF margin1.1%+1.0pp

Returns & leverage

See full
Debt / equity3.6×-3.4×
Current ratio0.9×+0.1×

Where this comes from

Calculated from Cencora’s reported figures.

Based on trailing twelve months.

The source filing: Cencora’s 10-Q, filed August 6, 2025. Open the filing →

Filed
Aug 6, 2025
Fiscal quarter
Q3 FY2025
Calendar quarter
Q2 2025
Accession
0001140859-25-000122

FAQ

What is Cencora's return on equity?
Cencora (COR) reported return on equity of 130.6% in Q2 2025.
How has Cencora's return on equity changed year-over-year?
Cencora's return on equity decreased by 43.3% year-over-year, from 230.4% to 130.6%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Ask your AI about Cencora's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude